Molecular Modeling Guided Drug Designing for the Therapeutic Treatment of Rheumatoid Arthritis

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td class="align_center"><object data="https://static.hindawi.com/articles/cmi/volume-2022/7360782/figures/7360782.tab-inline.001.svgz" name="7360782.tab-inline.001" type="image/svg+xml"></object></td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>HIA: human intestinal absorption; HOB: human oral bioavailability; ERB: estrogen receptor binding; ARB: androgen receptor binding; TRB: thyroid receptor binding; hERG CI: human ether-a-go-go-related gene channel inhibition; green color: potentially liable with transporter/channel; light green color: liable with transporter/channel; red color: does not show liability with transporters; light red color: slightly shows transporter liability.<br/></div></td></tr></table>

<div>Physicochemical properties and drug toxicity liability profiling of identified hits.</div>

Cellular Microbiology

tab6

Table 6

Table 6: Molecular Modeling Guided Drug Designing for the Therapeutic Treatment of Rheumatoid Arthritis 